Alpha Tau Medical (DRTSW) Stock Price, News & Analysis

Company Overview

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers. The minimally invasive procedure enables outpatient treatment sessions and can be combined with other modalities such as surgery, chemotherapy, and immunotherapy. Preclinical studies and early-phase clinical trials in Europe have demonstrated promising safety profiles and preliminary efficacy, supporting the continued advancement of multiple clinical programs.

Alpha Tau Medical maintains research and development operations in Rehovot, Israel, and U.S. offices in Houston, Texas, to support its global clinical development and regulatory activities. The company has secured the CE Mark in Europe for selected indications and is conducting multicenter trials in both Europe and the United States to expand its regulatory approvals. With a focus on partnerships and strategic collaborations, Alpha Tau Medical aims to integrate its alpha-therapy platform into standard-of-care regimens and broaden patient access to its treatments.

Key Stats

• Today's Range: $0.35 to $0.38
• 50-Day Range: $0.22 to $0.37
• 52-Week Range: $0.13 to $0.50
• Volume: 14,288 shs
• Average Volume: 19,226 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DRTSW Stock Analysis - Frequently Asked Questions

How have DRTSW shares performed this year?

Alpha Tau Medical's stock was trading at $0.21 on January 1st, 2025. Since then, DRTSW stock has increased by 77.1% and is now trading at $0.3720.

How do I buy shares of Alpha Tau Medical?

Shares of DRTSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:DRTSW
• CIK: 1871321
• Web: www.alphatau.com
• Phone: 972 3 577 4115
• Fax: N/A
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A